3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
37
Advanced Breast Cancer
5
Neoplasm Metastasis
4
Neoplasms
2
The Neoadjuvant Therapy
1
Solid Tumor, Adult
1
Recurrent Uterine Corpus Carcinoma
1
Hormone Receptor-positive Advanced Breast Cancer
1
Hormone Receptor Positive Advanced Breast Cancer
1
HR-positive, HER2-negative and PIK3CA Mutation Advanced Breast Cancer
1
HR Positive/HER-2 Negative Breast Cancer
1
Estrogen Receptor-positive Breast Cancer
1
Carcinoma, Intraductal, Noninfiltrating
1
Carcinoma, Ductal, Breast
1
Breast Neoplasm Female
1
Breast Diseases
1
Breast Carcinoma In Situ
1
Breast Cancer Organoids
1
Brain Neoplasms
1
Interventions
pyrotinib
1
palbociclib
1
Trastuzumab
1
Fulvestrant
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Estrogen Receptor-positive Breast Cancer
×
Fulvestrant
×
Clear all
NCT05076695
2021-10-13
NeoTPPF
Fudan University
Phase 2
Unknown
37 enrolled